Andres Martin, Lawrence Scahill, Christopher Kratochvil
Oxford University Press, Dec 14, 2010 - Medical - 840 pages
When the first edition of Pediatric Psychopharmacology published in 2002, it filled a void in child and adolescent psychiatry and quickly establishing itself as the definitive text-reference in pediatric psychopharmacology. While numerous short, clinically focused paperbacks have been published since then, no competitors with the scholarly breadth, depth, and luster of this volume have emerged. In the second edition, Christopher Kratochvil, MD, a highly respected expert in pediatric psychopharmacology, joins the outstanding editorial team led by Dr. Martin and Dr. Scahill. In the new edition, the editors streamline the flow of information to reflect the growth in scientific data since the first edition appeared. The overall structure of the book remains the same, with major sections on underlying biology; somatic interventions; assessment and treatment; and special considerations.
What people are saying - Write a review
We haven't found any reviews in the usual places.
Other editions - View all
abnormalities Academy of Child activity ADHD Adolescent Psychiatry Adolescent Psychopharmacology adults adverse effects aggression American Academy American Journal amygdala antidepressants antipsychotic anxiety disorders Archives assessment associated attention-deficit hyperactivity attention-deficit hyperactivity disorder autism behavior Biederman Biological Psychiatry bipolar disorder brain cells Child and Adolescent children and adolescents clinician clonidine cognitive comorbid controlled cortical decreased deficit developmental diagnostic dopamine dose double-blind drug efficacy fluoxetine function gene genetic guanfacine hyperactivity disorder increased inhibition inhibitors interactions Journal of Child Journal of Clinical Journal of Psychiatry Leckman lithium major depression medication metabolism methylphenidate mg/day monitoring mood neural neurons Neuroscience obsessive-compulsive disorder olanzapine parents paroxetine patients pediatric Pharmacokinetics pharmacological pharmacotherapy placebo placebo-controlled prefrontal cortex protein Psychopharmacology receptors reported Research response reuptake risk risperidone Scahill schizophrenia serotonin sertraline SSRIs stimulant symptoms therapeutic therapy tic disorders tion Tourette syndrome Tourette’s treated treatment trial weight gain youth